It will take you further to article about Dr. Lanza.
The new ACT clinical trial led by Dr. Steven Schwartz has proven the potential, safety and efficacy of stem cell-based therapy. We are pretty optimistic about future outcomes of these therapeutic approaches to macular diseases.